IS6610A - Nýjar blöndur alfa-2,4-dísúlfófenýl-N-tert-bútýlnítróns - Google Patents

Nýjar blöndur alfa-2,4-dísúlfófenýl-N-tert-bútýlnítróns

Info

Publication number
IS6610A
IS6610A IS6610A IS6610A IS6610A IS 6610 A IS6610 A IS 6610A IS 6610 A IS6610 A IS 6610A IS 6610 A IS6610 A IS 6610A IS 6610 A IS6610 A IS 6610A
Authority
IS
Iceland
Prior art keywords
butylnitron
disulfophenyl
tert
alpha
new mixtures
Prior art date
Application number
IS6610A
Other languages
English (en)
Inventor
J. Andersson Mats
Andersson Mattias
Eriksson Patrik
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of IS6610A publication Critical patent/IS6610A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Toxicology (AREA)
  • Psychiatry (AREA)
  • Biochemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IS6610A 2000-05-23 2002-11-11 Nýjar blöndur alfa-2,4-dísúlfófenýl-N-tert-bútýlnítróns IS6610A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0001916A SE0001916D0 (sv) 2000-05-23 2000-05-23 Novel formulation
PCT/SE2001/001164 WO2001089507A1 (en) 2000-05-23 2001-05-22 NOVEL FORMULATIONS OF α-2,4-DISULFOPHENYL-N-TERT-BUTYLNITRONE

Publications (1)

Publication Number Publication Date
IS6610A true IS6610A (is) 2002-11-11

Family

ID=20279797

Family Applications (1)

Application Number Title Priority Date Filing Date
IS6610A IS6610A (is) 2000-05-23 2002-11-11 Nýjar blöndur alfa-2,4-dísúlfófenýl-N-tert-bútýlnítróns

Country Status (29)

Country Link
US (2) US20030181527A1 (is)
EP (1) EP1294369B1 (is)
JP (1) JP3744857B2 (is)
KR (1) KR20030001545A (is)
CN (1) CN1268326C (is)
AR (1) AR030218A1 (is)
AT (1) ATE303803T1 (is)
AU (2) AU2001260935B2 (is)
BR (1) BR0111055A (is)
CA (1) CA2408781A1 (is)
CZ (1) CZ20023849A3 (is)
DE (1) DE60113255T2 (is)
DK (1) DK1294369T3 (is)
EE (1) EE200200653A (is)
ES (1) ES2247112T3 (is)
HU (1) HUP0302310A3 (is)
IL (1) IL152533A0 (is)
IS (1) IS6610A (is)
MX (1) MXPA02011533A (is)
MY (1) MY130445A (is)
NO (1) NO20025461D0 (is)
NZ (1) NZ522329A (is)
PL (1) PL361284A1 (is)
RU (1) RU2271800C2 (is)
SE (1) SE0001916D0 (is)
SK (1) SK16542002A3 (is)
TW (1) TWI259078B (is)
WO (1) WO2001089507A1 (is)
ZA (1) ZA200208747B (is)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050182060A1 (en) * 2004-02-13 2005-08-18 Kelly Michael G. 2-Substituted and 4-substituted aryl nitrone compounds
WO2010100135A1 (en) 2009-03-05 2010-09-10 Ablynx N.V. Novel antigen binding dimer-complexes, methods of making/avoiding and uses thereof
US9265834B2 (en) 2009-03-05 2016-02-23 Ablynx N.V. Stable formulations of polypeptides and uses thereof
EP2470015B1 (en) * 2009-08-24 2016-01-13 Hough Ear Institute Nitrone compounds for treating sensorineural hearing loss
PT2473528E (pt) * 2009-09-03 2015-03-04 Ablynx NV Formulações estáveis de polipéptidos e seus usos
EP2512489A4 (en) * 2009-12-15 2014-04-02 Merck Sharp & Dohme FORMULATIONS FROM ACADESIN
CA2826602C (en) * 2011-02-04 2019-06-11 Hough Ear Institute Methods for treating brain injury
CN104768532B (zh) * 2012-10-25 2017-11-28 费森尤斯卡比肿瘤学有限公司 5‑氮杂‑2’脱氧胞苷的稳定的药物组合物
US10660851B2 (en) 2015-01-02 2020-05-26 Rxos Medical Polyfunctional radical scavenger hydrogel formulation
CN116650411A (zh) * 2022-02-25 2023-08-29 广州喜鹊医药有限公司 一种注射用硝酮嗪药物组合物及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991005552A1 (en) * 1989-10-17 1991-05-02 Oklahoma Medical Research Foundation Method and compositions for inhibition of disorders associated with oxidative damage
JP2813023B2 (ja) * 1990-03-13 1998-10-22 株式会社神戸製鋼所 Ｍｉｓ型ダイヤモンド電界効果トランジスタ
US5488145A (en) * 1993-12-23 1996-01-30 Oklahoma Medical Research Foundation 2,4-disulfonyl phenyl butyl nitrone, its salts, and their use as pharmaceutical free radical traps

Also Published As

Publication number Publication date
CA2408781A1 (en) 2001-11-29
ES2247112T3 (es) 2006-03-01
BR0111055A (pt) 2003-04-15
SK16542002A3 (sk) 2003-04-01
DK1294369T3 (da) 2005-11-14
EE200200653A (et) 2004-06-15
WO2001089507A1 (en) 2001-11-29
NZ522329A (en) 2004-07-30
PL361284A1 (en) 2004-10-04
MXPA02011533A (es) 2003-04-25
TWI259078B (en) 2006-08-01
JP3744857B2 (ja) 2006-02-15
KR20030001545A (ko) 2003-01-06
US20080161406A1 (en) 2008-07-03
AU2001260935B2 (en) 2005-05-19
RU2271800C2 (ru) 2006-03-20
AU6093501A (en) 2001-12-03
US20030181527A1 (en) 2003-09-25
CN1268326C (zh) 2006-08-09
CZ20023849A3 (cs) 2003-05-14
NO20025461L (no) 2002-11-14
DE60113255D1 (de) 2005-10-13
JP2003534276A (ja) 2003-11-18
CN1430510A (zh) 2003-07-16
NO20025461D0 (no) 2002-11-14
HK1051649A1 (en) 2003-08-15
IL152533A0 (en) 2003-05-29
RU2002129588A (ru) 2004-03-27
DE60113255T2 (de) 2006-06-08
ATE303803T1 (de) 2005-09-15
EP1294369A1 (en) 2003-03-26
ZA200208747B (en) 2004-02-10
HUP0302310A2 (hu) 2003-11-28
MY130445A (en) 2007-06-29
SE0001916D0 (sv) 2000-05-23
AR030218A1 (es) 2003-08-13
HUP0302310A3 (en) 2005-06-28
EP1294369B1 (en) 2005-09-07

Similar Documents

Publication Publication Date Title
PT1259508E (pt) Novos biarilcarboxamidas
FI20011339L (fi) Hissi
DE60132410D1 (de) Resonator
DE60107598D1 (de) Smart-skin strukturen
EP1310252A4 (en) INJECTIONS
AR027983A1 (es) Novedosos compuestos
DE50109453D1 (de) Resonatoranordnung
DE50101315D1 (de) Förderpumpe
EP1264611A4 (en) SYRINGE
DE50103731D1 (de) Förderpumpe
DE60045199D1 (de) Aufzug
IS6610A (is) Nýjar blöndur alfa-2,4-dísúlfófenýl-N-tert-bútýlnítróns
DE10196460T1 (de) Selbstzerstör-Spritze
DE50112030D1 (de) Förderpumpe
AR028220A1 (es) Novedosos compuestos
DE60043080D1 (de) Fahrtreppe
DE50111939D1 (de) Förderpumpe
EP1284232A4 (en) LIFT
FI114251B (fi) Resonaattorisuodatin
EP1329411A4 (en) LIFT DEVICE
DE60105505D1 (de) Resonator
AR028399A1 (es) Nuevos compuestos
DE50114606D1 (de) Schalungsmaterial
ATA22000A (de) Mauerwerk
NO20001452D0 (no) Sprøyte